Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 734 shares at $76.00 ($56K) on 2026-01-05, disclosed to the SEC on 2026-01-06.
Seasonal sale ($56k) by Director — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-07 | $3.4M | — | Filing → |